Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...
The 2024 conference has 28 late-breakers plus plenty of basic and population science. More than anything, it’s a celebration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback